Neurologic disorders are present in 15% to 30% of AIDS patients. The p
hysiologic isolation imposed by the brain and blood-brain barrier have
Limited characterization of the disorders and assessment of therapy.
Only time will tell whether the multidrug antiretroviral regimens that
have shown such success in controlling HIV in the systemic compartmen
t will be equally effective in suppressing brain viremia.